HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,919,054 | +4.8% | 311,666 | -0.4% | 0.90% | +12.5% |
| Q2 2023 | $26,648,447 | +5.3% | 312,996 | +2.4% | 0.80% | +2.3% |
| Q1 2023 | $25,303,680 | +7.9% | 305,784 | +2.6% | 0.78% | +5.7% |
| Q4 2022 | $23,449,497 | +3.6% | 298,150 | -2.5% | 0.74% | -3.4% |
| Q3 2022 | $22,644,000 | +4.6% | 305,871 | -7.9% | 0.77% | +18.6% |
| Q2 2022 | $21,640,000 | +10.2% | 332,011 | +6.9% | 0.65% | +30.2% |
| Q1 2022 | $19,637,000 | +16.7% | 310,615 | -2.1% | 0.50% | +25.9% |
| Q4 2021 | $16,830,000 | -26.2% | 317,312 | -1.8% | 0.39% | -26.4% |
| Q3 2021 | $22,801,000 | +37.0% | 323,000 | +29.4% | 0.54% | +40.4% |
| Q2 2021 | $16,639,000 | -43.2% | 249,678 | -5.3% | 0.38% | -41.5% |
| Q1 2021 | $29,276,000 | +6.5% | 263,728 | +13.9% | 0.65% | 0.0% |
| Q4 2020 | $27,487,000 | +29.0% | 231,470 | -5.3% | 0.65% | +5.3% |
| Q3 2020 | $21,316,000 | – | 244,309 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |